Nitric oxide/cGMP protects endothelial cells from hypoxia-mediated leakiness

European Journal of Cell Biology

Volumn 87, Issue 3, 2008, Pages 147-161

  Kolluru, Gopi Krishna ^a   Tamilarasan, K P ^a   Rajkumar, Arun Stephen ^a   Geetha Priya, S ^a   Rajaram, Megha ^a   Saleem, Niyas K ^a   Majumder, Syamantak ^a   Jaffar Ali, B M ^a   Illavazagan, G ^b   Chatterjee, Suvro ^a  

^a ANNA UNIVERSITY   (India)

^b DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

Author keywords

Actin filaments; cGMP; Endothelial cells; Hypoxia; Nitric oxide; Sildenafil

Indexed keywords

8 BROMO CYCLIC GMP; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; F ACTIN; NITRIC OXIDE; PHALLOIDIN; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

ALTITUDE; ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; CELL HYPOXIA; CELL IMMORTALIZATION; CELL MEMBRANE PERMEABILITY; CELL PROTECTION; CONTROLLED STUDY; COW; CYTOCHEMISTRY; CYTOSKELETON; DEPOLYMERIZATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPOTHESIS; LUNG BLOOD VESSEL; LUNG EDEMA; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; UMBILICAL CORD; VASCULAR ENDOTHELIUM;

BOVINAE;

EID: 39149125446     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2007.10.001     Document Type: Article

References (61)

1. Ahn G.J., Yu J.Y., Choi S.M., Kang K.K., Ahn B.O., Kwon J.W., Kang S.K., Lee B.C., and Hwang W.S. Chronic administration of phosphodiesterase 5 inhibitor improves erectile and endothelial function in a rat model of diabetes. Int. J. Androl. 28 (2005) 260-266
2. Alexander J.S., Hechtman H.B., and Shepro D. Phalloidin enhances endothelial barrier function and reduces inflammatory permeability in vitro. Microvasc. Res. 35 (1988) 308-315
3. Anand I.S., Prasad B.A., Chugh S.S., Rao K.R., Cornfield D.N., Milla C.E., Singh N., Singh S., and Selvamurthy W. Effects of inhaled nitric oxide and oxygen in high-altitude pulmonary edema. Circulation 98 (1998) 2441-2445
4. Antonova G., Snead C., Antonov A., Dimitropoulou C., Venema R.C., and Catravas J.D. Nitric oxide preconditioning regulates endothelial monolayer integrity via the heat shock protein 90-soluble guanylate cyclase pathway. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H893-H903
5. Arias-Stella J., and Kruger H. Pathology of high altitude pulmonary edema. Arch. Pathol. 70 (1963) 43-53
6. Arkowitz M., Wispe J.R., Garcia V.F., and Szabo C. Selective inhibition of the inducible isoform of nitric oxide synthase prevents pulmonary transvascular flux during acute endotoxemia. J. Pediatr. Surg. 31 (1997) 1009-1015
7. Baldwin A.L., Thurston G., and Al Naemi H. Inhibition of nitric oxide synthesis increases venular permeability and alters endothelial actin cytoskeleton. Am. J. Physiol. Heart Circ. Physiol. 274 (1998) H1776-H1784
8. Benzing A., Mols G., Guttmann J., Kaltofen H., and Geiger K. Effect of different doses of inhaled nitric oxide on pulmonary capillary pressure and on longitudinal distribution of pulmonary vascular resistance in ARDS. Br. J. Anaesth. 80 (1998) 440-446
9. Boiadjieva S., Hallberg C., Hogstrom M., and Busch C. Exclusion of trypan blue from microcarriers by endothelial cells: an in vitro barrier function test. Methods Lab. Invest. 50 (1984) 239-246
10. Botto L., Beretta E., Daffara R., Miserocchi G., and Palestini P. Biochemical and morphological changes in endothelial cells in response to hypoxic interstitial edema. Respir. Res. 7 (2006) 7
11. Brigham K.L., and Owen P.J. Increased sheep lung vascular permeability caused by histamine. Circ. Res. 37 (1975) 647-657
12. Brigham K.L., Woolverton W.C., Blake L.H., and Staub N.C. Increased sheep lung vascular permeability caused by Pseudomonas bacteremia. J. Clin. Invest. 54 (1974) 792-804
13. Chatterjee S., Cao S., and Shah V. Inhibition of GTP-dependent vesicle trafficking impairs internalization of plasmalemmal eNOS and cellular nitric oxide production. J. Cell Sci. 116 (2002) 3645-3655
14. Dai J., and Sheetz M.P. Mechanical properties of neuronal growth cone membranes studied by tether formation with laser optical tweezers. Biophys. J. 68 (1995) 988-996
15. Dai J., and Sheetz M.P. Cell membrane mechanics. Methods Cell Biol. 55 (1998) 157-171
16. Draijer R., Atsma D.E., van der Laarse A., and van Hinsbergh V.W. cGMP and nitric oxide modulate thrombin-induced endothelial permeability. Regulation via different pathways in human aortic and umbilical vein endothelial cells. Circ. Res. 76 (1995) 199-208
17. Evans E., Heinrich V., Leung A., and Kinoshita K. Nano- to microscale dynamics of P-selectin detachment from leukocyte interfaces. I. Membrane separation from the cytoskeleton. Biophys. J. 88 (2005) 2288-2298
18. Garat C., Jayr C., Eddahibi S., Laffon M., Meigan M., and Adnot S. Effects of inhaled nitric oxide or inhibition of endogenous nitric oxide formation on hyperoxic lung injury. Am. J. Respir. Crit. Care Med. 155 (1997) 1957-1964
19. Gertzberg N., Neumann P., Rizzo V., and Johnson A. NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-alpha. Am. J. Physiol. Lung Cell Mol. Physiol. 286 (2004) L37-L48
20. Goligorsky M.S., Abedi H., Noiri E., Takhtajan A., Lense S., Victor R., and Zachary I. Nitric oxide modulation of focal adhesions in endothelial cells. Am. J. Physiol. Cell Physiol. 276 (1999) C1271-C1281
21. Grankvist K., Lernmark A., and Täljedal I.B. Trypan blue as a marker of plasma membrane permeability in alloxan-treated mouse islet cells. J. Endocrinol. Invest. 2 (1979) 139-145
22. Groot R.D., and Rabone K.L. Mesoscopic simulation of cell membrane damage, morphology change and rupture by nonionic surfactants. Biophys. J. 81 (2001) 725-736
23. Himashree G., Dass D., Banerjee P.K., and Selvamurthy W. Nitric oxide and the respiratory system. Curr. Sci. 85 (2003) 607-614
24. Hinder F., Stubbe H.D., Van Aken H., Waurick R., Booke M., and Meyer J. Role of nitric oxide in sepsis-associated pulmonary edema. Am. J. Respir. Crit. Care Med. 159 (1999) 252-257
25. Hultgren J.N. High altitude pulmonary edema. In: Staub N.C. (Ed). Lung Water and Solute Exchange (1978), Marcel Dekker, Inc., New York 437-469
26. Ignarro L.J. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J. Physiol. Pharmacol. 53 (2002) 503-514
27. Ignarro L.J. Wei Lun Visiting Professorial Lecture: nitric oxide in the regulation of vascular function: an historical overview. J. Cardiac Surg. 17 (2002) 301-306
28. Inoue M., Sato E.F., Park A.M., Nishikawa M., Kasahara E., Miyoshi M., Ochi A., and Utsumi K. Cross-talk between NO and oxyradicals, a supersystem that regulates energy metabolism and survival of animals. Free Radic. Res. 33 (2000) 757-770
29. Irwin D.C., Tissot van Patot M.C., Tucker A., and Bowen R. Direct ANP inhibition of hypoxia-induced inflammatory pathways in pulmonary microvascular and macrovascular endothelial monolayers. Am. J. Physiol. Lung Cell Mol. Physiol. 288 (2005) L849-L859
30. Kawasaki K., Smith R.S., Hsieh C.M., Sun J., Chao J., and Liao J.K. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol. Cell. Biol. 23 (2003) 5726-5737
31. Kayyali U.S., Pennella C.M., Trujillo C., Villa O., Gaestel M., and Hassoun P.M. Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2. J. Biol. Chem. 277 (2002) 42596-42602
32. Kelly J.J., Moore T.M., Babal P., Diwan A.H., Stevens T., and Thompson W.J. Pulmonary microvascular and macrovascular endothelial cells: differential regulation of Ca2+ and permeability. Am. J. Physiol. Lung Cell Mol. Physiol. 274 (1998) L810-L819
33. Kinsella J.P., Truog W.E., Walsh W.F., Goldberg R.N., Bancalari E., Mayock D.E., Redding G.J., deLemos R.A., Sardesai S., McCurnin D.C., Moreland S.G., Cutter G.R., and Abman S.H. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J. Pediatr. 131 (1997) 55-62
34. Lagrange P., Romero I.A., Minn A., and Revest P.A. Transendothelial permeability changes induced by free radicals in an in vitro model of the blood-brain barrier. Free Radic. Biol. Med. 27 (1999) 667-672
35. Maggiorini M., Melot C., Pierre S., Pfeiffer F., Greve I., Sartori C., Lepori M., Hauser M., Scherrer U., and Naeije R. High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 4 (2001) 2078-2083
36. Marumo T., Noll T., Schini-Kerth V.B., Harley E.A., Duhault J., Piper H.M., and Busse R. Significance of nitric oxide and peroxynitrite in permeability changes of the retinal microvascular endothelial cell monolayer induced by vascular endothelial growth factor. J. Vasc. Res. 36 (1999) 510-515
37. Matthay M.A. Alveolar fluid clearance in patients with ARDS: does it make a difference?. Chest 122 (2002) 340S-343S
38. Moncada S. Nitric oxide in the vasculature: physiology and pathophysiology. Ann. NY Acad. Sci. 811 (1997) 60-67 discussion 67-69.
39. Moncada S. Nitric oxide: discovery and impact on clinical medicine. J. R. Soc. Med. 92 (1999) 164-169
40. Mukhopadhyay S., Xu F., and Sehgal P.B. Aberrant cytoplasmic sequestration of eNOS in endothelial cells after monocrotaline, hypoxia, and senescence: live-cell caveolar and cytoplasmic NO imaging. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H1373-H1389
41. Mundy A.L., and Dorrington K.L. Inhibition of nitric oxide synthesis augments pulmonary oedema in isolated perfused rabbit lung. Br. J. Anaesth. 85 (2000) 570-576
42. Omura A., Roy R., and Jennings T. Inhaled nitric oxide improves survival in the rat model of high-altitude pulmonary edema. Wild. Environ. Med. 11 (2000) 251-256
43. Perrin G., Roch A., Michelet P., Reynaud-Gaubert M., Thomas P., Doddoli C., and Auffray J.P. Inhaled nitric oxide does not prevent pulmonary edema after lung transplantation measured by lung water content: a randomized clinical study. Chest 129 (2006) 1024-1030
44. Poss W.B., Timmons O.D., Farrukh I.S., Hoidal J.R., and Michael J.R. Inhaled nitric oxide prevents the increase in pulmonary vascular permeability caused by hydrogen peroxide. J. Appl. Physiol. 79 (1995) 886-891
45. Predescu D., Predescu S., Shimizu J., Miyawaki-Shimizu K., and Malik A.B. Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am. J. Physiol. Lung Cell Mol. Physiol. 289 (2005) L371-L381
46. Preston I.R., Hill N.S., Gambardella L.S., Warburton R.R., and Klinger J.R. Synergistic effects of ANP and sildenafil on cGMP levels and amelioration of acute hypoxic pulmonary hypertension. Exp. Biol. Med. 229 (2004) 920-925
47. Rasio E.A., Bendayan M., Goresky C.A., Alexander J.S., and Shepro D. Effect of phalloidin on structure and permeability of rete capillaries in the normal and hypoxic state. Circ. Res. 65 (1989) 591-599
48. Roberts Jr. J.D., Fineman J.R., Morin III F.C., Shaul P.W., Rimar S., Schreiber M.D., Polin R.A., Zwass M.S., Zayek M.M., Gross I., Heymann M.A., and Zapol W.M. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N. Engl. J. Med. 336 (1997) 605-610
49. Ryan U.S. Isolation and culture of pulmonary endothelial cells. Environ. Health Perspect. 56 (1984) 103-114
50. Sartori, C., Allemann, Y., Scherrer, U., 2007. Pathogenesis of pulmonary edema: learning from high-altitude pulmonary edema. Respir. Physiol. Neurobiol. [E-pub ahead of print, doi:10.1016/j.resp.2007.04.006].
51. Scherrer U., Vollenweider L., Delabays A., Savcic M., Eichenberger U., Kleger G.R., Fikrle A., Ballmer P.E., Nicod P., and Bärtsch P. Inhaled nitric oxide for high-altitude pulmonary edema. N. Engl. J. Med. 334 (1996) 624-629
52. Searles C.D., Ide L., Davis M.E., Cai H., and Weber M. Actin cytoskeleton organization and posttranscriptional regulation of endothelial nitric oxide synthase during cell growth. Circ. Res. 95 (2004) 488-495
53. Sessa W.C. eNOS at a glance. J. Cell Sci. 117 (2004) 2427-2429
54. Suttorp N., Weber U., Welsch T., and Schudt C. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J. Clin. Invest. 91 (1993) 1421-1428
55. Suttorp N., Hippensteil S., Fuhrmann M., Krüll M., and Podzuweit T. Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability. Am. J. Physiol. Cell Physiol. 39 (1996) C778-C785
56. Thomas M.K., Francis S.H., and Corbin J.D. Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase. J. Biol. Chem. 265 (1990) 14964-14970
57. Tiruppathi C., Malik A.B., Vecchio P.J.D., Keese C.R., and Giaever I. Electrical method for detection of endothelial cell shape change in real time: assessment of endothelial barrier function. Proc. Natl. Acad. Sci. USA 89 (1992) 7919-7923
58. Van Nieuw Amerongen G.P., and van Hinsbergh V.W. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vasc. Pharmacol. 39 (2002) 257-272
59. Vogel C., Bauer A., Wiesnet M., Preissner K.T., Schaper W., Marti H.H., and Fischer S. Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway. J. Cell. Physiol. 212 (2007) 236-243
60. Wessel D.L., Adatia I., Van Marter L.J., Thompson J.E., Kane J.W., Stark A.R., and Kourembanas S. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 100 (1997) E7
61. Zhu B., Strada S., and Stevens T. Cyclic GMP-specific phosphodiesterase 5 regulates growth and apoptosis in pulmonary endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 289 (2005) L196-L206